Kogarahboy, the impression you're giving from this post is that there is an underlying acknowledgement that the image and image quality produced by EMVision's Gen 1 device are somehow not up to a high quality standard or are not currently "fit for purpose."
Do I understand this correctly?
Where did you get this impression from?
If you could link to a source from either a professional clinician (from outside the company) or from anyone within the company where this concern has been expressed I'd be very interested. I'm really trying to understand where these concerns are coming from because I've never heard them expressed before?
On the contrary, all the images from our pilot trial were excellent in quality and in diagnosis sensitivity.
Have you read the announcements pertaining to our pilot trial?
Please don't take this post as an attack. It is not. I'm just trying to understand where you're coming from with your concerns.
https://www.aspecthuntley.com.au/asxdata/20201028/pdf/02300191.pdf
EMvision Research Notes, page-1947
-
- There are more pages in this discussion • 634 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
0.033(1.64%) |
Mkt cap ! $172.5M | |||
| Open | High | Low | Value | Volume |
| $1.98 | $2.02 | $1.94 | $41.93K | 21.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1272 | $1.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.03 | 4500 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| EMV (ASX) Chart |